Details of Drug

Drug General Information (ID: D1522)
Drug Name	Sunitinib
Drug Type	Small molecule
Drug Synonymous	Sunitanib; Sunitinibum; Sutent; PDGF TK antagonist; SU 11248; SU11248; KS-5022; SU-11248; SU-11248J; SU-12662; Su-011248; Sunitinib (INN); Sunitinib (free base); Sutent (TN); N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; 5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE; Sunitinib (Pan-TK inhibitor) Click to Show/Hide
Disease Class	2B5B: Gastrointestinal stromal tumour; 2C11: Malignant digestive organ neoplasm
Therapeutic Class	Antineoplastics
Structure
Structure	3D Structure		2D Structure
Formula	C22H27FN4O2
InChI	1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-
InChIKey	WINHZLLDWRZWRT-ATVHPVEESA-N
Canonical SMILES	CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
External Link
	Pubchem ID	5329102
	CAS Number	557795-19-4
	CHEBI ID	38940
	TTD ID	D0R0MW
	VARIDT ID	DR00454

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects BM010 Transporter inhibition BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM038 Additive CNS depression effects BM044 Additive myelosuppressive effects BM049 Increased risk of atrioventricular block BM050 Increased risk of bleeding BM051 Increased risk of bradycardia BM055 Increased risk of hepatotoxicity BM064 Increased risk of hypoglycemia BM074 Increased risk of peripheral neuropathy BM076 Increased risk of prolong QT interval BM081 Increased risk of ventricular arrhythmias BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Sunitinib
Affected cellular transport
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 28
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1398		Ribociclib	C23H30N8O	44631912	Major		Inter Info	[1], [2], [3], [152], [153], [154], [13]
D0080		Amprenavir	C25H35N3O6S	65016	Moderate		Inter Info	[2], [281], [21]
D0116		Atazanavir	C38H52N6O7	148192	Moderate		Inter Info	[2], [281], [21]
D0349		Clarithromycin	C38H69NO13	84029	Moderate		Inter Info	[2], [281], [21]
D0386		Conivaptan	C32H26N4O2	151171	Moderate		Inter Info	[2], [281], [21]
D0439		Delavirdine	C22H28N6O3S	5625	Moderate		Inter Info	[2], [281], [21]
D0597		Erythromycin	C37H67NO13	12560	Moderate		Inter Info	[2], [281], [21]
D0799		Indinavir	C36H47N5O4	5362440	Moderate		Inter Info	[2], [281], [21]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Moderate		Inter Info	[2], [281], [21]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Moderate		Inter Info	[2], [281], [21]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[352]
D1117		Nefazodone	C25H32ClN5O2	4449	Moderate		Inter Info	[2], [281], [21]
D1119		Nelfinavir	C32H45N3O4S	64143	Moderate		Inter Info	[2], [281], [21]
D1415		Ritonavir	C37H48N6O5S2	392622	Moderate		Inter Info	[2], [281], [21]
D0002		Abametapir (topical)	C12H12N2	15664	Moderate		Inter Info	[386]
D0171		Berotralstat	C30H26F4N6O	137528262	Moderate		Inter Info	[390]
D0192		Boceprevir	C27H45N5O5	10324367	Moderate		Inter Info	[1], [21]
D0375		Cobicistat	C40H53N7O5S2	25151504	Moderate		Inter Info	[2], [281], [21]
D0543		Duvelisib	C22H17ClN6O	50905713	Moderate		Inter Info	[394]
D0638		Fedratinib	C27H36N6O3S	16722836	Moderate		Inter Info	[3], [398]
D0692		Fosamprenavir	C25H36N3O9PS	131536	Moderate		Inter Info	[2], [281], [21]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[399]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Moderate		Inter Info	[2], [3], [405]
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Moderate		Inter Info	[2], [281], [21]
D1541		Telaprevir	C36H53N7O6	3010818	Moderate		Inter Info	[2], [281], [21]
D1653		Troleandomycin	C41H67NO15	202225	Moderate		Inter Info	[2], [281], [21]
D1660		Tucatinib	C26H24N8O2	51039094	Moderate		Inter Info	[2], [281], [21]
D1544		Telithromycin	C43H65N5O10	3002190	Moderate		Inter Info	[2], [281], [21]
	CYP450 enzyme induction					Drug Num: 51
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0255		Carbamazepine	C15H12N2O	2554	Major		Inter Info	[2], [3], [21]
D1078		Mitotane	C14H10Cl4	4211	Major		Inter Info	[2], [3], [21]
D1265		Phenobarbital	C12H12N2O3	4763	Major		Inter Info	[2], [3], [21]
D1283		Phenytoin	C15H12N2O2	1775	Major		Inter Info	[2], [3], [21]
D1340		Primidone	C12H14N2O2	4909	Major		Inter Info	[2], [3], [21]
D1400		Rifampicin	C43H58N4O12	135398735	Major		Inter Info	[2], [3], [21]
D1401		Rifapentine	C47H64N4O12	135403821	Major		Inter Info	[2], [3], [21]
D0095		Apalutamide	C21H15F4N5O2S	24872560	Major		Inter Info	[2], [3], [21]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Major		Inter Info	[2], [3], [21]
D0697		Fosphenytoin	C16H15N2O6P	56339	Major		Inter Info	[2], [3], [21]
D0958		Lumacaftor	C24H18F2N2O5	16678941	Major		Inter Info	[2], [3], [21]
D1502		St. John's Wort	NA	NA	Major		Inter Info	[2], [3], [21]
D0061		Aminoglutethimide	C13H16N2O2	2145	Moderate		Inter Info	[2], [3], [21]
D0194		Bosentan	C27H29N5O6S	104865	Moderate		Inter Info	[2], [3], [21]
D0224		Butabarbital	C10H16N2O3	2479	Moderate		Inter Info	[2], [3], [21]
D0225		Butalbital	C11H16N2O3	2481	Moderate		Inter Info	[2], [3], [21]
D0639		Felbamate	C11H14N2O4	3331	Moderate		Inter Info	[2], [3], [21]
D0741		Griseofulvin	C17H17ClO6	441140	Moderate		Inter Info	[2], [3], [21]
D1040		Methylphenobarbital	C13H14N2O3	8271	Moderate		Inter Info	[2], [3], [21]
D1081		Modafinil	C15H15NO2S	4236	Moderate		Inter Info	[2], [3], [21]
D1099		Nafcillin	C21H22N2O5S	8982	Moderate		Inter Info	[2], [3], [21]
D1128		Nevirapine	C15H14N4O	4463	Moderate		Inter Info	[2], [3], [21]
D1198		Oxcarbazepine	C15H12N2O2	34312	Moderate		Inter Info	[2], [3], [21]
D1248		Pentobarbital	C11H18N2O3	4737	Moderate		Inter Info	[2], [3], [21]
D1274		Phenylbutazone	C19H20N2O2	4781	Moderate		Inter Info	[2], [3], [21]
D1399		Rifabutin	C46H62N4O11	135398743	Moderate		Inter Info	[2], [3], [21]
D1453		Secobarbital	C12H18N2O3	5193	Moderate		Inter Info	[2], [3], [21]
D1494		Somatotropin	NA	NA	Moderate		Inter Info	[2], [3], [21]
D1518		Sulfinpyrazone	C23H20N2O3S	5342	Moderate		Inter Info	[2], [3], [21]
D0071		Amobarbital	C11H18N2O3	2164	Moderate		Inter Info	[2], [3], [21]
D0106		Armodafinil	C15H15NO2S	9690109	Moderate		Inter Info	[2], [3], [21]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Moderate		Inter Info	[2], [3], [21]
D0300		Cenobamate	C10H10ClN5O2	11962412	Moderate		Inter Info	[2], [3], [21]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[2], [3], [21]
D0432		Deferasirox	C21H15N3O4	214348	Moderate		Inter Info	[2], [3], [21]
D0545		Echinacea	NA	NA	Moderate		Inter Info	[2], [395]
D0555		Elagolix	C32H30F5N3O5	11250647	Moderate		Inter Info	[2], [3], [21]
D0601		Eslicarbazepine	C15H14N2O2	9881504	Moderate		Inter Info	[2], [3], [21]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[2], [3], [21]
D0732		Glycerol phenylbutyrate	C33H38O6	10482134	Moderate		Inter Info	[2], [3], [21]
D0901		Lemborexant	C22H20F2N4O2	56944144	Moderate		Inter Info	[2], [3], [21]
D0905		Lesinurad	C17H14BrN3O2S	53465279	Moderate		Inter Info	[2], [3], [21]
D0953		Lorlatinib	C21H19FN6O2	71731823	Moderate		Inter Info	[2], [3], [21]
D1050		Metreleptin	NA	NA	Moderate		Inter Info	[2], [3], [21]
D1186		Oritavancin	C86H97Cl3N10O26	16136912	Moderate		Inter Info	[2], [3], [21]
D1433		Rufinamide	C10H8F2N4O	129228	Moderate		Inter Info	[2], [3], [21]
D1493		Somapacitan	C54H95N13O20S2	129894493	Moderate		Inter Info	[2], [3], [21]
D1495		Somatrem	C43H72N14O14	5487805	Moderate		Inter Info	[2], [3], [21]
D1538		Tazemetostat	C34H44N4O4	66558664	Moderate		Inter Info	[2], [3], [21]
D1546		Telotristat ethyl	C27H26ClF3N6O3	25181577	Moderate		Inter Info	[2], [3], [21]
D1652		Troglitazone	C24H27NO5S	5591	Moderate		Inter Info	[2], [3], [21]
Pharmacodynamic additive effects
	Additive CNS depression effects					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0452		Deutetrabenazine	C19H27NO3	73437646	Moderate		Inter Info	[393]
D1673		Valbenazine	C24H38N2O4	24795069	Moderate		Inter Info	[415]
	Additive myelosuppressive effects					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0370		Clozapine	C18H19ClN4	135398737	Major		Inter Info	[47], [48]
D0433		Deferiprone	C7H9NO2	2972	Major		Inter Info	[2], [136], [137]
	Increased risk of atrioventricular block					Drug Num: 22
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0010		Acebutolol	C18H28N2O4	1978	Moderate		Inter Info	[21], [173]
D0117		Atenolol	C14H22N2O3	2249	Moderate		Inter Info	[21], [173]
D0173		Betaxolol	C18H29NO3	2369	Moderate		Inter Info	[21], [173]
D0188		Bisoprolol	C18H31NO4	2405	Moderate		Inter Info	[21], [173]
D0265		Carteolol	C16H24N2O3	2583	Moderate		Inter Info	[21], [173]
D0267		Carvedilol	C24H26N2O4	2585	Moderate		Inter Info	[21], [173]
D0491		Digoxin	C41H64O14	2724385	Moderate		Inter Info	[21], [173]
D0497		Diltiazem	C22H26N2O4S	39186	Moderate		Inter Info	[21], [173]
D0602		Esmolol	C16H25NO4	59768	Moderate		Inter Info	[21], [173]
D0884		Labetalol	C19H24N2O3	3869	Moderate		Inter Info	[21], [173]
D0992		Mefloquine	C17H16F6N2O	4046	Moderate		Inter Info	[3], [87], [173]
D1049		Metoprolol	C15H25NO3	4171	Moderate		Inter Info	[21], [173]
D1088		Moricizine	C22H25N3O4S	34633	Moderate		Inter Info	[21], [173]
D1098		Nadolol	C17H27NO4	39147	Moderate		Inter Info	[21], [173]
D1293		Pindolol	C14H20N2O2	4828	Moderate		Inter Info	[21], [173]
D1357		Propranolol	C16H21NO2	4946	Moderate		Inter Info	[21], [173]
D0490		Digitoxin	C41H64O13	441207	Moderate		Inter Info	[21], [173]
D0885		Lacosamide	C13H18N2O3	219078	Moderate		Inter Info	[21], [173]
D1114		Nebivolol	C22H25F2NO4	71301	Moderate		Inter Info	[21], [173]
D1244		Penbutolol	C18H29NO2	37464	Moderate		Inter Info	[21], [173]
D1585		Timolol	C13H24N4O3S	33624	Moderate		Inter Info	[21], [173]
D1690		Verapamil	C27H38N2O4	2520	Moderate		Inter Info	[21], [173]
	Increased risk of bleeding					Drug Num: 18
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0129		Avapritinib	C26H27FN10	118023034	Major		Inter Info	[3], [131]
D1718		Zanubrutinib	C27H29N5O3	135565884	Major		Inter Info	[159]
D0087		Anisindione	C16H12O3	2197	Moderate		Inter Info	[3], [144], [21]
D0102		Ardeparin	C26H42N2O37S5	772	Moderate		Inter Info	[3], [144], [21]
D0104		Argatroban	C23H36N6O5S	92722	Moderate		Inter Info	[3], [144], [21]
D0189		Bivalirudin	C98H138N24O33	16129704	Moderate		Inter Info	[3], [144], [21]
D0481		Dicoumarol	C19H12O6	54676038	Moderate		Inter Info	[3], [144], [21]
D0574		Enoxaparin	C26H42N2O37S5	772	Moderate		Inter Info	[3], [144], [21]
D0753		Heparin	C26H42N2O37S5	772	Moderate		Inter Info	[3], [144], [21]
D0904		Lepirudin	C287H440N80O111S6	118856773	Moderate		Inter Info	[3], [144], [21]
D0096		Apixaban	C25H25N5O4	10182969	Moderate		Inter Info	[3], [144], [21]
D0176		Betrixaban	C23H22ClN5O3	10275777	Moderate		Inter Info	[3], [144], [21]
D0414		Dalteparin	C26H42N2O37S5	772	Moderate		Inter Info	[3], [144], [21]
D0415		Danaparoid	NA	NA	Moderate		Inter Info	[3], [144], [21]
D0447		Desirudin	C287H440N80O110S6	16129703	Moderate		Inter Info	[3], [144], [21]
D0551		Edoxaban	C24H30ClN7O4S	10280735	Moderate		Inter Info	[3], [144], [21]
D1417		Rivaroxaban	C19H18ClN3O5S	9875401	Moderate		Inter Info	[3], [144], [21]
D1588		Tinzaparin	C26H42N2O37S5	772	Moderate		Inter Info	[3], [144], [21]
	Increased risk of bradycardia					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0031		Alectinib	C30H34N4O2	49806720	Moderate		Inter Info	[387], [388]
	Increased risk of hepatotoxicity					Drug Num: 20
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[1], [96], [97]
D0944		Lomitapide	C39H37F6N3O2	9853053	Major		Inter Info	[143]
D1073		Mipomersen	C230H324N67O122P19S19	118984467	Major		Inter Info	[146]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[151]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[1], [96], [97]
D0114		Asparaginase Escherichia coli	NA	NA	Moderate		Inter Info	[289], [290], [291], [2], [3], [292], [293], [294], [295], [296], [297], [298], [299]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[300]
D0826		Interferon beta-1a	NA	NA	Moderate		Inter Info	[345], [346], [347], [348]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[345], [346], [347], [348]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[3], [362]
D1106		Naltrexone	C20H23NO4	5360515	Moderate		Inter Info	[364]
D1234		Pegaspargase	C14H19NO	436058	Moderate		Inter Info	[289], [290], [291], [2], [3], [292], [293], [294], [295], [296], [297], [298], [299]
D0113		Asparaginase Erwinia chrysanthemi	NA	NA	Moderate		Inter Info	[289], [290], [291], [2], [3], [292], [293], [294], [295], [296], [297], [298], [299]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[391]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[3], [392]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[403]
D1239		Peginterferon beta-1a	NA	NA	Moderate		Inter Info	[345], [346], [347], [348]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[2], [3], [410], [411], [412]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[3], [414]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[417], [418]
	Increased risk of hypoglycemia					Drug Num: 21
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0013		Acetohexamide	C15H20N2O4S	1989	Moderate		Inter Info	[174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274]
D0325		Chlorpropamide	C10H13ClN2O3S	2727	Moderate		Inter Info	[174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274]
D0727		Glimepiride	C24H34N4O5S	3476	Moderate		Inter Info	[174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274]
D0728		Glipizide	C21H27N5O4S	3478	Moderate		Inter Info	[174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274]
D0730		Glyburide	C23H28ClN3O5S	3488	Moderate		Inter Info	[174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274]
D0811		Insulin glargine	C267H404N72O78S6	118984454	Moderate		Inter Info	[174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [338], [185], [186], [187], [188], [189], [190], [191], [192], [194], [195], [196], [198], [199], [200], [201], [203], [204], [205], [207], [209], [210], [211], [212], [213], [214], [215], [216], [217], [219], [222], [224], [225], [226], [229], [230], [232], [233], [234], [236], [339], [238], [340], [341], [243], [342], [343], [249], [251], [252], [253], [255], [257], [259], [261], [262], [266], [267], [268], [269], [344], [270], [271], [273], [274]
D0813		Insulin human	C257H383N65O77S6	118984375	Moderate		Inter Info	[181], [238], [255]
D0814		Insulin human (inhalation, rapid acting)	C257H383N65O77S6	118984375	Moderate		Inter Info	[181], [238], [255]
D0815		Insulin human (isophane)	C257H383N65O77S6	118984375	Moderate		Inter Info	[181], [238], [255]
D0816		Insulin human (regular)	C257H383N65O77S6	118984375	Moderate		Inter Info	[181], [238], [255]
D0817		Insulin human (zinc extended)	C257H383N65O77S6	118984375	Moderate		Inter Info	[181], [238], [255]
D0818		Insulin human (zinc)	C257H383N65O77S6	118984375	Moderate		Inter Info	[181], [238], [255]
D0819		Insulin lispro	C257H389N65O77S6	16132438	Moderate		Inter Info	[174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [338], [185], [186], [187], [188], [189], [190], [191], [192], [194], [195], [196], [198], [199], [200], [201], [203], [204], [205], [207], [209], [210], [211], [212], [213], [214], [215], [216], [217], [219], [222], [224], [225], [226], [229], [230], [232], [233], [234], [236], [339], [238], [340], [341], [243], [342], [343], [249], [251], [252], [253], [255], [257], [259], [261], [262], [266], [267], [268], [269], [344], [270], [271], [273], [274]
D0820		Insulin lispro (protamine)	C257H389N65O77S6	16132438	Moderate		Inter Info	[181], [238], [255]
D1112		Nateglinide	C19H27NO3	5311309	Moderate		Inter Info	[174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274]
D1392		Repaglinide	C27H36N2O4	65981	Moderate		Inter Info	[174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274]
D0807		Insulin aspart (aspart protamine)	C256H381N65O79S6	118984445	Moderate		Inter Info	[181], [238], [255]
D0808		Insulin aspart (aspart)	C256H381N65O79S6	118984445	Moderate		Inter Info	[181], [238], [255]
D0809		Insulin degludec	C274H411N65O81S6	118984462	Moderate		Inter Info	[174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [338], [185], [186], [187], [188], [189], [190], [191], [192], [194], [195], [196], [198], [199], [200], [201], [203], [204], [205], [207], [209], [210], [211], [212], [213], [214], [215], [216], [217], [219], [222], [224], [225], [226], [229], [230], [232], [233], [234], [236], [339], [238], [340], [341], [243], [342], [343], [249], [251], [252], [253], [255], [257], [259], [261], [262], [266], [267], [268], [269], [344], [270], [271], [273], [274]
D0810		Insulin detemir	C267H402N64O76S6	16137271	Moderate		Inter Info	[174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [338], [185], [186], [187], [188], [189], [190], [191], [192], [194], [195], [196], [198], [199], [200], [201], [203], [204], [205], [207], [209], [210], [211], [212], [213], [214], [215], [216], [217], [219], [222], [224], [225], [226], [229], [230], [232], [233], [234], [236], [339], [238], [340], [341], [243], [342], [343], [249], [251], [252], [253], [255], [257], [259], [261], [262], [266], [267], [268], [269], [344], [270], [271], [273], [274]
D0812		Insulin glulisine	C258H384N64O78S6	16136701	Moderate		Inter Info	[174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [338], [185], [186], [187], [188], [189], [190], [191], [192], [194], [195], [196], [198], [199], [200], [201], [203], [204], [205], [207], [209], [210], [211], [212], [213], [214], [215], [216], [217], [219], [222], [224], [225], [226], [229], [230], [232], [233], [234], [236], [339], [238], [340], [341], [243], [342], [343], [249], [251], [252], [253], [255], [257], [259], [261], [262], [266], [267], [268], [269], [344], [270], [271], [273], [274]
	Increased risk of prolong QT interval					Drug Num: 171
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0084		Anagrelide	C10H7Cl2N3O	135409400	Major		Inter Info	[1], [2], [3], [14]
D0170		Bepridil	C24H34N2O	2351	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0320		Chloroquine	C18H26ClN3	2719	Major		Inter Info	[22], [3], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40]
D0342		Cisapride	C23H29ClFN3O4	6917698	Major		Inter Info	[1], [2], [3], [41], [42], [43]
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[1], [2], [3], [44], [45], [13], [46]
D0508		Disopyramide	C21H29N3O	3114	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0513		Dofetilide	C19H27N3O5S2	71329	Major		Inter Info	[1], [2], [3], [49]
D0514		Dolasetron	C19H20N2O3	3033818	Major		Inter Info	[1], [2], [3], [50]
D0535		Droperidol	C22H22FN3O2	3168	Major		Inter Info	[1], [2], [3], [51], [52], [13]
D0554		Efavirenz	C14H9ClF3NO2	64139	Major		Inter Info	[53]
D0599		Escitalopram	C20H21FN2O	146570	Major		Inter Info	[1], [54], [2], [3], [55], [56], [13]
D0712		Gatifloxacin	C19H22FN3O4	5379	Major		Inter Info	[57], [58], [59], [1], [2], [3], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D0740		Grepafloxacin	C19H22FN3O3	72474	Major		Inter Info	[58], [1], [2], [3], [80], [81], [82]
D0749		Halofantrine	C26H30Cl2F3NO	37393	Major		Inter Info	[83], [1], [2], [3], [84], [85], [86], [87], [88]
D0750		Haloperidol	C21H23ClFNO2	3559	Major		Inter Info	[1], [2], [3], [89], [90], [91], [92], [93], [94], [13]
D0787		Ibutilide	C20H36N2O3S	60753	Major		Inter Info	[1], [2], [3], [95]
D0909		Levacetylmethadol	C23H31NO2	15130	Major		Inter Info	[3], [98], [13]
D1010		Mesoridazine	C21H26N2OS2	4078	Major		Inter Info	[1], [2], [3], [99], [13]
D1017		Methadone	C21H27NO	4095	Major		Inter Info	[1], [2], [3], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [13]
D1063		Mifepristone	C29H35NO2	55245	Major		Inter Info	[1], [2], [3], [110]
D1092		Moxifloxacin	C21H24FN3O4	152946	Major		Inter Info	[57], [58], [59], [1], [2], [3], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D1223		Papaverine	C20H21NO4	4680	Major		Inter Info	[111], [112], [113], [114], [115], [116], [117], [118]
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[3], [51], [119], [13]
D1343		Procainamide	C13H21N3O	4913	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1444		Saquinavir	C38H50N6O5	441243	Major		Inter Info	[120], [121], [1], [2], [3], [122], [123]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1499		Sparfloxacin	C19H22F2N4O3	60464	Major		Inter Info	[58], [1], [2], [3], [124], [125], [62], [64], [66], [126], [67], [68], [127], [70], [71], [72], [73], [128], [77], [82], [129]
D0067		Amisulpride	C17H27N3O4S	2159	Major		Inter Info	[130]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Major		Inter Info	[132]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[3], [133]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[1], [2], [3], [134]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[135]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[1], [2], [3], [138]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Major		Inter Info	[22], [3], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[1], [2], [3], [140], [13]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Major		Inter Info	[141]
D0899		Lefamulin	C28H45NO5S	25185057	Major		Inter Info	[142]
D0960		Lumefantrine	C30H32Cl3NO	6437380	Major		Inter Info	[2], [3], [144]
D0965		Macimorelin	C26H30N6O3	9804938	Major		Inter Info	[145]
D1136		Nilotinib	C28H22F3N7O	644241	Major		Inter Info	[1], [2], [3], [48]
D1190		Osimertinib	C28H33N7O2	71496458	Major		Inter Info	[147]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[149]
D1230		Pasireotide	C58H66N10O9	9941444	Major		Inter Info	[1], [2], [3], [150]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[3], [155]
D1681		Vandetanib	C22H24BrFN4O2	3081361	Major		Inter Info	[1], [2], [3], [157]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Major		Inter Info	[1], [2], [3], [158]
D1574		Thioridazine	C21H26N2S2	5452	Major		Inter Info	[1], [2], [3], [160], [51], [161], [162], [163], [13]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[1], [2], [3], [164]
D1726		Ziprasidone	C21H21ClN4OS	60854	Major		Inter Info	[1], [2], [3], [51], [165], [13]
D0003		Abarelix	C72H95ClN14O14	16131215	Moderate		Inter Info	[3], [166], [167], [168], [169], [170], [171], [172]
D0036		Alfuzosin	C19H27N5O4	2092	Moderate		Inter Info	[1], [2], [3], [153], [13]
D0037		Alimemazine	C18H22N2S	5574	Moderate		Inter Info	[1], [2], [21]
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[1], [2], [3], [21]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[1], [2], [3], [21]
D0097		Apomorphine	C17H17NO2	6005	Moderate		Inter Info	[1], [2], [3], [282], [13]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[2], [3], [283], [284], [285], [286], [287], [288]
D0115		Astemizole	C28H31FN4O	2247	Moderate		Inter Info	[1], [2], [3], [21]
D0119		Atomoxetine	C17H21NO	54841	Moderate		Inter Info	[1], [2], [3], [21]
D0139		Azithromycin	C38H72N2O12	447043	Moderate		Inter Info	[1], [2], [3], [21]
D0180		Bicalutamide	C18H14F4N2O4S	2375	Moderate		Inter Info	[3], [166], [167], [168], [169], [170], [171], [172]
D0219		Buprenorphine	C29H41NO4	644073	Moderate		Inter Info	[1], [2], [3], [21]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[1], [2], [3], [21]
D0336		Cilostazol	C20H27N5O2	2754	Moderate		Inter Info	[1], [2], [3], [21]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[1], [2], [3], [21]
D0358		Clofazimine	C27H22Cl2N4	2794	Moderate		Inter Info	[301]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[1], [2], [3], [21]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[302]
D0429		Daunorubicin	C27H29NO10	30323	Moderate		Inter Info	[1], [2], [3], [21]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Moderate		Inter Info	[1], [2], [21]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[1], [2], [3], [21]
D0467		Dextropropoxyphene	C22H29NO2	10100	Moderate		Inter Info	[1], [2], [21]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[1], [2], [3], [21]
D0528		Doxorubicin	C27H29NO11	31703	Moderate		Inter Info	[1], [2], [3], [21]
D0529		Doxorubicin (liposomal)	C27H29NO11	31703	Moderate		Inter Info	[1], [2], [21]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[1], [2], [3], [21]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[2], [3], [306]
D0664		Flecainide	C17H20F6N2O3	3356	Moderate		Inter Info	[1], [2], [3], [21]
D0667		Fluconazole	C13H12F2N6O	3365	Moderate		Inter Info	[1], [2], [3], [21]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[1], [2], [3], [21]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[1], [2], [3], [21]
D0682		Flutamide	C11H11F3N2O3	3397	Moderate		Inter Info	[3], [166], [167], [168], [169], [170], [171], [172]
D0694		Foscarnet	CH3O5P	3415	Moderate		Inter Info	[1], [2], [3], [21]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Moderate		Inter Info	[58], [66], [67], [72], [337]
D0737		Goserelin	C59H84N18O14	5311128	Moderate		Inter Info	[3], [166], [167], [168], [169], [170], [171], [172]
D0738		Granisetron	C18H24N4O	5284566	Moderate		Inter Info	[1], [2], [3], [21]
D0751		Halothane	C2HBrClF3	3562	Moderate		Inter Info	[1], [2], [3], [21]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Moderate		Inter Info	[1], [2], [3], [21]
D0788		Idarubicin	C26H27NO9	42890	Moderate		Inter Info	[1], [2], [3], [21]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[1], [2], [3], [21]
D0908		Leuprolide	C59H84N16O12	657181	Moderate		Inter Info	[3], [166], [167], [168], [169], [170], [171], [172]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[58], [1], [2], [3], [62], [63], [64], [353], [354], [67], [68], [355], [69], [356], [70], [71], [72], [73], [357], [358], [359], [77], [82]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Moderate		Inter Info	[3]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Moderate		Inter Info	[1], [2], [3], [21]
D0947		Loperamide	C29H33ClN2O2	3955	Moderate		Inter Info	[360], [361]
D0979		Maprotiline	C20H23N	4011	Moderate		Inter Info	[1], [2], [3], [21]
D1075		Mirtazapine	C17H19N3	4205	Moderate		Inter Info	[363]
D1137		Nilutamide	C12H10F3N3O4	4493	Moderate		Inter Info	[3], [166], [167], [168], [169], [170], [171], [172]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[58], [1], [2], [3], [62], [63], [64], [353], [354], [67], [68], [355], [69], [356], [70], [71], [72], [73], [357], [358], [359], [77], [82]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[1], [2], [3], [21]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[58], [1], [2], [3], [62], [63], [64], [353], [354], [67], [68], [355], [69], [356], [70], [71], [72], [73], [357], [358], [359], [77], [82]
D1166		Olanzapine	C17H20N4S	135398745	Moderate		Inter Info	[2], [3], [365]
D1181		Ondansetron	C18H19N3O	4595	Moderate		Inter Info	[1], [2], [3], [21]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[1], [2], [3], [21]
D1210		Oxytocin	C43H66N12O12S2	439302	Moderate		Inter Info	[1], [2], [3], [21]
D1215		Paliperidone	C23H27FN4O3	115237	Moderate		Inter Info	[1], [2], [3], [21]
D1216		Palonosetron	C19H24N2O	6337614	Moderate		Inter Info	[1], [2], [3], [21]
D1246		Pentamidine	C19H24N4O2	4735	Moderate		Inter Info	[1], [2], [3], [21]
D1254		Perflutren	C3F8	6432	Moderate		Inter Info	[366], [367]
D1257		Perphenazine	C21H26ClN3OS	4748	Moderate		Inter Info	[1], [2], [3], [21]
D1315		Posaconazole	C37H42F2N8O4	468595	Moderate		Inter Info	[1], [2], [3], [21]
D1339		Primaquine	C15H21N3O	4908	Moderate		Inter Info	[1], [2], [3], [21]
D1346		Prochlorperazine	C20H24ClN3S	4917	Moderate		Inter Info	[1], [2], [3], [21]
D1351		Promazine	C17H20N2S	4926	Moderate		Inter Info	[1], [2], [3], [21]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[1], [2], [3], [21]
D1353		Propafenone	C21H27NO3	4932	Moderate		Inter Info	[1], [2], [3], [21]
D1356		Propofol	C12H18O	4943	Moderate		Inter Info	[368], [369], [370], [371], [372], [373], [374], [375], [376], [377]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[1], [2], [3], [21]
D1368		Quetiapine	C21H25N3O2S	5002	Moderate		Inter Info	[1], [2], [3], [51], [378], [379], [380], [381], [13]
D1372		Quinine	C20H24N2O2	3034034	Moderate		Inter Info	[1], [2], [3], [21]
D1383		Ranolazine	C24H33N3O4	56959	Moderate		Inter Info	[382], [383]
D1413		Risperidone	C23H27FN4O2	5073	Moderate		Inter Info	[1], [2], [3], [21]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[1], [2], [3], [21]
D1463		Sevoflurane	C4H3F7O	5206	Moderate		Inter Info	[1], [2], [3], [384]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Moderate		Inter Info	[1], [2], [3], [385]
D0007		Abiraterone	C24H31NO	132971	Moderate		Inter Info	[3], [166], [167], [168], [169], [170], [171], [172]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[1], [2], [3], [389], [13]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Moderate		Inter Info	[3], [154]
D0437		Degarelix	C82H103ClN18O16	16136245	Moderate		Inter Info	[3], [166], [167], [168], [169], [170], [171], [172]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[396]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[1], [2], [3], [397]
D0632		Ezogabine	C16H18FN3O2	121892	Moderate		Inter Info	[1], [2], [3], [21]
D0700		Fostemsavir	C25H26N7O8P	11319217	Moderate		Inter Info	[400]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[401]
D0725		Glasdegib	C21H22N6O	25166913	Moderate		Inter Info	[402]
D0758		Histrelin	C66H86N18O12	25077993	Moderate		Inter Info	[3], [166], [167], [168], [169], [170], [171], [172]
D0806		Inotuzumab ozogamicin	NA	NA	Moderate		Inter Info	[3], [404]
D0903		Lenvatinib	C21H19ClN4O4	9823820	Moderate		Inter Info	[1], [2], [3], [21]
D0940		Lithium carbonate	CLi2O3	11125	Moderate		Inter Info	[1], [2], [21]
D0942		Lofexidine	C11H12Cl2N2O	30668	Moderate		Inter Info	[1], [2], [3], [406], [13]
D1026		Methotrimeprazine	C19H24N2OS	72287	Moderate		Inter Info	[1], [2], [3], [21]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[1], [2], [3], [21]
D1169		Oliceridine	C22H30N2O2S	66553195	Moderate		Inter Info	[1], [2], [3], [21]
D1189		Osilodrostat	C13H10FN3	44139752	Moderate		Inter Info	[1], [2], [3], [21]
D1232		Pazopanib	C21H23N7O2S	10113978	Moderate		Inter Info	[1], [2], [3], [21]
D1290		Pimavanserin	C25H34FN3O2	10071196	Moderate		Inter Info	[409]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[1], [2], [3], [21]
D1342		Probucol	C31H48O2S2	4912	Moderate		Inter Info	[1], [2], [3], [21]
D1388		Relugolix	C29H27F2N7O5S	10348973	Moderate		Inter Info	[3], [166], [167], [168], [169], [170], [171], [172]
D1404		Rilpivirine	C22H18N6	6451164	Moderate		Inter Info	[1], [2], [3], [21]
D1424		Romidepsin	C24H36N4O6S2	5352062	Moderate		Inter Info	[1], [2], [3], [21]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[1], [2], [3], [21]
D1491		Solifenacin	C23H26N2O2	154059	Moderate		Inter Info	[1], [2], [3], [21]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Moderate		Inter Info	[1], [2], [3], [21]
D1634		Triclabendazole	C14H9Cl3N2OS	50248	Moderate		Inter Info	[1], [2], [3], [21]
D1651		Triptorelin	C64H82N18O13	25074470	Moderate		Inter Info	[3], [166], [167], [168], [169], [170], [171], [172]
D1526		Tacrolimus	C44H69NO12	445643	Moderate		Inter Info	[1], [2], [3], [21]
D1533		Tamoxifen	C26H29NO	2733526	Moderate		Inter Info	[1], [2], [3], [21]
D1555		Terfenadine	C32H41NO2	5405	Moderate		Inter Info	[1], [2], [3], [21]
D1596		Tizanidine	C9H8ClN5S	5487	Moderate		Inter Info	[1], [2], [3], [21]
D1616		Tramadol	C16H25NO2	33741	Moderate		Inter Info	[1], [2], [3], [21]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[419], [420], [283], [421], [422], [423], [13]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[1], [2], [3], [21]
D1638		Triflupromazine	C18H19F3N2S	5568	Moderate		Inter Info	[1], [2], [3], [21]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[1], [2], [3], [21]
D1682		Vardenafil	C23H32N6O4S	135400189	Moderate		Inter Info	[1], [2], [3], [21]
D1683		Vasopressin	C46H65N15O12S2	644077	Moderate		Inter Info	[1], [2], [3], [21]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[1], [2], [3], [21]
D1051		Metronidazole	C6H9N3O3	4173	Minor		Inter Info	[2], [424], [425], [426]
D1516		Sulfamethoxazole	C10H11N3O3S	5329	Minor		Inter Info	[1], [2], [3], [427], [428], [429], [430]
	Increased risk of ventricular arrhythmias					Drug Num: 37
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0107		Arsenic trioxide	As2O3	14888	Major		Inter Info	[15], [16]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[1], [2], [3], [139], [46]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[148]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[2], [156]
D0025		Adenosine	C10H13N5O4	60961	Moderate		Inter Info	[1], [275], [2], [3], [276], [277], [278], [41], [279], [280]
D0516		Donepezil	C24H29NO3	3152	Moderate		Inter Info	[1], [2], [3], [303], [304], [305]
D0691		Formoterol	C19H24N2O4	3410	Moderate		Inter Info	[307], [308], [309], [310], [311], [312], [313], [314], [315], [316], [317], [318], [319], [320], [321], [322], [323], [324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336]
D0707		Galantamine	C17H21NO3	9651	Moderate		Inter Info	[1], [2], [3], [303], [304], [305]
D0854		Isoetharine	C13H21NO3	3762	Moderate		Inter Info	[307], [308], [309], [310], [311], [312], [313], [314], [315], [316], [317], [318], [319], [320], [321], [322], [323], [324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336]
D0859		Isoprenaline	C11H17NO3	3779	Moderate		Inter Info	[320], [330], [333]
D0888		Lactulose	C12H22O11	11333	Moderate		Inter Info	[1], [2], [3], [349], [350], [351]
D1185		Orciprenaline	C11H17NO3	4086	Moderate		Inter Info	[320], [330], [333]
D1414		Ritodrine	C17H21NO3	33572	Moderate		Inter Info	[307], [308], [309], [310], [311], [312], [313], [314], [315], [316], [317], [318], [319], [320], [321], [322], [323], [324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336]
D1418		Rivastigmine	C14H22N2O2	77991	Moderate		Inter Info	[1], [2], [3], [303], [304], [305]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[307], [308], [309], [310], [311], [312], [313], [314], [315], [316], [317], [318], [319], [320], [321], [322], [323], [324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[307], [308], [309], [310], [311], [312], [313], [314], [315], [316], [317], [318], [319], [320], [321], [322], [323], [324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336]
D0184		Bisacodyl	C22H19NO4	2391	Moderate		Inter Info	[1], [2], [3], [349], [350], [351]
D0269		Castor oil	C57H104O9	14030006	Moderate		Inter Info	[1], [2], [3], [349], [350], [351]
D0701		Frangula purshiana bark	NA	NA	Moderate		Inter Info	[2], [3], [351]
D0731		Glycerin	C3H8O3	753	Moderate		Inter Info	[1], [2], [3], [349], [350], [351]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[307], [308], [309], [310], [311], [312], [313], [314], [315], [316], [317], [318], [319], [320], [321], [322], [323], [324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336]
D0887		Lactitol	C12H24O11	157355	Moderate		Inter Info	[1], [2], [3], [349], [350], [351]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[320], [330], [333]
D0970		Magnesium citrate	C12H10Mg3O14	6099959	Moderate		Inter Info	[1], [2], [3], [349], [350], [351]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[1], [2], [3], [349], [350], [351]
D1069		Mineral oil	NA	NA	Moderate		Inter Info	[1], [2], [3], [349], [350], [351]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[307], [308], [309], [310], [311], [312], [313], [314], [315], [316], [317], [318], [319], [320], [321], [322], [323], [324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336]
D1266		Phenolphthalein	C20H14O4	4764	Moderate		Inter Info	[1], [2], [3], [349], [350], [351]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[3], [407], [408]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[307], [308], [309], [310], [311], [312], [313], [314], [315], [316], [317], [318], [319], [320], [321], [322], [323], [324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[3], [407], [408]
D1309		Polyethylene glycol (3350)	C2H6O2	174	Moderate		Inter Info	[2], [3], [351]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[3], [407], [408]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[320], [330], [333]
D1525		Tacrine	C13H14N2	1935	Moderate		Inter Info	[1], [2], [3], [303], [304], [305]
D1554		Terbutaline	C12H19NO3	5403	Moderate		Inter Info	[307], [308], [309], [310], [311], [312], [313], [314], [315], [316], [317], [318], [319], [320], [321], [322], [323], [324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[2], [3], [416]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 10
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0177		Bevacizumab	NA	NA	Major		Inter Info	[17], [18], [19]
D0178		Bexarotene	C24H28O2	82146	Major		Inter Info	[3], [20]
D0034		Alendronic acid	C4H13NO7P2	2088	Moderate		Inter Info	[2], [3], [21]
D0623		Etidronic acid	C2H8O7P2	3305	Moderate		Inter Info	[2], [3], [21]
D0783		Ibandronate	C9H23NO7P2	60852	Moderate		Inter Info	[2], [3], [21]
D1217		Pamidronic acid	C3H11NO7P2	4674	Moderate		Inter Info	[2], [3], [21]
D1412		Risedronic acid	C7H11NO7P2	5245	Moderate		Inter Info	[2], [3], [21]
D1426		Romosozumab	NA	NA	Moderate		Inter Info	[413]
D1584		Tiludronic acid	C7H9ClO6P2S	60937	Moderate		Inter Info	[2], [3], [21]
D1727		Zoledronic acid	C5H10N2O7P2	68740	Moderate		Inter Info	[2], [3], [21]

References
1	Canadian Pharmacists Association.
2	Cerner Multum, Inc. "Australian Product Information.".
3	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
4	Maxa JL, Hebeler RF, Adeeko MA "Torsades de pointes following concurrent amiodarone and levofloxacin therapy." Proc (Bayl Univ Med Cent) 19 (2006): 345-6. [PMID: 17106497]
5	Product Information. Betapace (sotalol). Berlex, Richmond, CA.
6	Product Information. Cordarone (amiodarone). Wyeth-Ayerst Laboratories, Philadelphia, PA.
7	Product Information. Norpace (disopyramide). Searle, Skokie, IL.
8	Product Information. Procan SR (procainamide). Parke-Davis, Morris Plains, NJ.
9	Product Information. Quiniglute (quinidine). Berlex, Richmond, CA.
10	Product Information. Vascor (bepridil). McNeil Pharmaceutical, Raritan, NJ.
11	Trujillo TC, Nolan PE "Antiarrhythmic agents - Drug interactions of clinical significance." Drug Safety 23 (2000): 509-32. [PMID: 11144659]
12	Yamreudeewong W, DeBisschop M, Martin L, Lower D "Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs." Drug Saf 26 (2003): 421-38. [PMID: 12688833]
13	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
14	Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
15	Ohnishi K, Yoshida H, Shigeno K, et al. "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia." Ann Intern Med 133 (2000): 881-5. [PMID: 11103058]
16	Product Information. Trisenox (arsenic trioxide) Cephalon Inc, West Chester, PA.
17	Product Information. Avastin (bevacizumab). Genentech, South San Francisco, CA.
18	Bevacizumab + sunitinib associated with MAHA.?React. Wkly.?1211, 2 (2008).
19	Genentech Inc.Microangiopathic hemolytic anemia (MAHA) in patients treated with Avastin (Rm) (bevacizumab) and sunitinib malate. Internet Document: [2 pages], Jul 2009.
20	Product Information. Targretin (bexarotene) Ligand Pharmaceuticals, San Diego, CA.
21	Product Information. Sutent (sunitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
22	Harper KM, Knapp DJ, Criswell HE, Breese GR "Vasopressin and alcohol: A multifaceted relationship." Psychopharmacology (Berl) 235 (2018): 3363-79. [PMID: 32936259]
23	Javelot H, El-Hage W, Meyer G, Becker G, Michel B, Hingray C "COVID-19 and (hydroxy)chloroquine-azithromycin combination: should we take the risk for our patients?" Br J Clin Pharmacol Apr 29 (2020): epub ahead of print. [PMID: 32350872]
24	National Institutes of Health (NIH) "Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.".
25	Product Information. Chloroquine Phosphate (chloroquine). West-Ward Pharmaceutical Corporation, Eatontown, NJ.
26	Product Information. Hydroxychloroquine Sulfate (hydroxychloroquine). Prasco Laboratories, Cincinnati, OH.
27	Product Information. Plaquenil (R). (hydroxychloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
28	Roden DM, Harrington RA, Poppas A, Russo AM "Considerations for drug interactions on QTc in exploratory COVID-19 (Coroanvirus disease 2019) treatment." Heart Rhythm Apr 14 (2020): epub ahead of print. [PMID: 32302703]
29	Sacher F, Fauchier L, Boveda S, et.al "Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection." Arch Cardiovasc Dis Apr 24 (2020): epub ahead of print. [PMID: 32354666]
30	Saleh M, Gabriels J, ChangD, et.al "The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection." Circ Arrhythm Electrophysiol Apr 29 (2020): epub ahead of print. [PMID: 32347743]
31	Sapp JL, Alqarawi W, MacIntyre CJ, et.al "Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: A statement from the Canadian Heart Rhythm Society." Can J Cardiol Apr 8 (2020): epub ahead of print. [PMID: 32299753]
32	Smit C, Peeters MYM, van den Anker JN, Knibbe CAJ "Chloroquine for SARS-CoV-2: Implications of its unique pharmacokinetic and safety properties." Clin Pharmacokinet Ar 18 (2020): epub ahead of print. [PMID: 32306288]
33	Bessiere F, Roccia H, Deliniere A, et.al "Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit." JAMA Cardiol May 1 (2020): epub ahead of print. [PMID: 32936266]
34	Borba MGS, Val FFA, Sampaio VS, et.al "Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 1 (SARS-CoV-2) infection: A randomized clinical trial." JAMA Netw Open Apr 1 (2020): epub ahead of print. [PMID: 32330277]
35	Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ "Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)" Mayo Clin Proc Apr 7 (2020): epub ahead of print. [PMID: 32359771]
36	Kapoor A, Pandurangi U, Arora V, et.al "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society." Indian Pacing Electorphysiol J Apr 8 (2020): epub ahead of print. [PMID: 32278018]
37	Mercuro NJ, Yen CF, Shim DJ, et.al "Risk of QT interval prolongation associated with the use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)" JAMA Cardiol May 1:e201834 (2020): epub ahead of print. [PMID: 32936252]
38	mitra RL, Greenstein SA, Epstein lm "An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin Possible benefits of intravenous lidocaine." HeartRythm Case Rep Apr 1 (2020): epub ahead of print. [PMID: 32363145]
39	US Food and Drug Administration "FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF CHLOROQUINE PHOSPHATE SUPPLIED FROM THE STRATEGIC NATIONAL STOCKPILE FOR TREATMENT OF COVID-19 IN CERTAIN HOSPITALIZED PATIENTS. Available from: URL: https://www.fda.gov/media/13653" ([2020, Apr 27]):.
40	US Food and Drug Administration "Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems.".
41	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
42	Product Information. Propulsid (cisapride). Janssen Pharmaceutica, Titusville, NJ.
43	Trinkle R "Comment: syncopal episodes associated with cisapride." Ann Pharmacother 33 (1999): 251. [PMID: 10084425]
44	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).".
45	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
46	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
47	Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
48	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
49	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
50	Product Information. Anzemet (dolasetron). Hoechst Marion-Roussel Inc, Kansas City, MO.
51	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
52	Product Information. Inapsine (droperidol). Janssen Pharmaceutica, Titusville, NJ.
53	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
54	Castro VM, Clements CC, Murphy SN, et al. "QT interval and antidepressant use: a cross sectional study of electronic health records." BMJ 346 (2013): f288. [PMID: 23360890]
55	Do A, Noohi S, Elie D, et al. Health Canada Warning on Citalopram and Escitalopram--Its Effects on Prescribing in Consultation-Liaison Psychiatry.?Psychosomatics. 2016;57(1):57-63. [PMID: 26633294]
56	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
57	Ansari SR, Chopra N "Gatifloxacin and Prolonged QT Interval." Am J Med Sci 327 (2004): 55-6. [PMID: 14722399]
58	Ball P "Quinolone-induced QT interval prolongation: a not-so-unexpected class effect." J Antimicrob Chemother 45 (2000): 557-9. [PMID: 10797074]
59	Bertino JS Jr, Owens RC Jr, Carnes TD, Iannini PB "Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors." Clin Infect Dis 34 (2002): 861-3. [PMID: 11830802]
60	Dale KM, Lertsburapa K, Kluger J, White CM "Moxifloxacin and torsade de pointes." Ann Pharmacother 41 (2007): 336-40. [PMID: 17284508]
61	Demolis JL, Kubitza D, Tenneze L, Funck-Bretano C "Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects." Clin Pharmacol Ther 68 (2000): 658-66. [PMID: 11180026]
62	Falagas ME, Rafailidis PI, Rosmarakis ES "Arrhythmias associated with fluoroquinolone therapy." Int J Antimicrob Agents 29 (2007): 374-9. [PMID: 17241772]
63	Frothingham R "Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin." Pharmacotherapy 21 (2001): 1468-72. [PMID: 11765299]
64	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
65	Iannini PB, Circiumaru I "Gatifloxacin-induced QTc prolongation and ventricular tachycardia." Pharmacotherapy 21 (2001): 361-2. [PMID: 11253862]
66	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs." BMJ 322 (2001): 46-7. [PMID: 11141163]
67	Kang J, Wang L, Chen XL, Triggle DJ, Rampe D "Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG." Mol Pharmacol 59 (2001): 122-6. [PMID: 11125032]
68	Katritsis D, Camm AJ "Quinolones: cardioprotective or cardiotoxic." Pacing Clin Electrophysiol 26 (2003): 2317-20. [PMID: 14675020]
69	Noel GJ, Natarajan J, Chien S, Hunt TL, Goodman DB, Abels R "Effects of three fluoroquinolones on QT interval in healthy adults after single doses." Clin Pharmacol Ther 73 (2003): 292-303. [PMID: 12709719]
70	Oliphant CM, Green GM "Quinolones: a comprehensive review." Am Fam Physician 65 (2002): 455-64. [PMID: 11858629]
71	Owens RC "QT Prolongation with Antimicrobial Agents : Understanding the Significance." Drugs 64 (2004): 1091-124. [PMID: 15139788]
72	Owens RC "Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes." Pharmacotherapy 21 (2001): 301-19. [PMID: 11253855]
73	Owens RC Jr, Ambrose PG "Torsades de pointes associated with fluoroquinolones." Pharmacotherapy 22 (2002): 663-8 discussion 668-72. [PMID: 12013370]
74	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
75	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
76	Siepmann M, Kirch W "Drug points - Tachycardia associated with moxifloxacin." Br Med J 322 (2001): 23. [PMID: 11141146]
77	Stahlmann R "Clinical toxicological aspects of fluoroquinolones." Toxicol Lett 127 (2002): 269-77. [PMID: 12052667]
78	Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF "Effects of three fluoroquinolones on QT analysis after standard treatment courses." Ann Noninvasive Electrocardiol 11 (2006): 52-6. [PMID: 16472283]
79	White CM, Grant EM, Quintiliani R "Moxifloxacin does increase the corrected QT interval." Clin Infect Dis 33 (2001): 1441-2. [PMID: 11565091]
80	Lode H, Vogel F, Elies W "Grepafloxacin: A review of its safety profile based on clinical trials and postmarketing surveillance." Clin Ther 21 (1999): 61-74. [PMID: 10090425]
81	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
82	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
83	Abernethy DR, Wesche DL, Barbey JT, et al. "Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation." Br J Clin Pharmacol 51 (2001): 231-7. [PMID: 11298069]
84	Giao PT, de Vries PJ "Pharmacokinetic interactions of antimalarial agents." Clin Pharmacokinet 40 (2001): 343-73. [PMID: 11432537]
85	Nosten F, ter Kuile FO, Luxemburger C, et al "Cardiac effects of antimalarial treatment with halofantrine." Lancet 341 (1993): 1054-6. [PMID: 8096959]
86	Product Information. Halfan (halofantrine). GlaxoSmithKline, Philadelphia, PA.
87	Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
88	Sudden death in a traveler following halofantrine administration--Togo, 2000. MMWR Morb Mortal Wkly Rep 50 (2001): 169-70, 179. [PMID: 11393488]
89	Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Matsuzaki I, Yonezawa Y "The association between intravenous haloperidol and prolonged QT interval." J Clin Psychopharmacol 21 (2001): 257-61. [PMID: 11386487]
90	Huyse F, van Schijndel RS "Haloperidol and cardiac arrest." Lancet 2 (1988): 568-9. [PMID: 2900948]
91	Metzger E, Friedman R "Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill." J Clin Psychopharmacol 13 (1993): 128-32. [PMID: 8463445]
92	O'Brien JM, Rockwood RP, Suh KI "Haloperidol-induced torsade de pointes." Ann Pharmacother 33 (1999): 1046-9. [PMID: 10534216]
93	Product Information. Haldol (haloperidol). McNeil Pharmaceutical, Raritan, NJ.
94	Wilt JL, Minnema AM, Johnson RF, Rosenblum AM "Torsade de pointes associated with the use of intravenous haloperidol." Ann Intern Med 119 (1993): 391-4. [PMID: 8338292]
95	Product Information. Corvert (ibutilide). Pharmacia and Upjohn, Kalamazoo, MI.
96	EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
97	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
98	Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
99	Product Information. Serentil (mesoridazine) Boehringer-Ingelheim, Ridgefield, CT.
100	De Bels D, Staroukine M, Devriendt J "Torsades de pointes due to methadone." Ann Intern Med 139 (2003): E156. [PMID: 12859181]
101	Ehret GB, Desmeules JA, Broers B "Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology." Expert Opin Drug Saf 6 (2007): 289-303. [PMID: 17480178]
102	Gil M, Sala M, Anguera I, et al. "QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone." Am J Cardiol 92 (2003): 995-7. [PMID: 14556883]
103	Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS "Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes." Pharmacotherapy 23 (2003): 802-5. [PMID: 12820821]
104	Krantz MJ, Lewkowiez L, Hays H, et al "Torsade de pointes associated with very-high-dose methadone." Ann Intern Med 137 (2002): 501-4. [PMID: 12230351]
105	Krantz MJ, Mehler PS "Synthetic opioids and QT prolongation." Arch Intern Med 163 (2003): 1615 author reply 1615. [PMID: 12860589]
106	Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN "Impact of methadone treatment on cardiac repolarization and conduction in opioid users." Am J Cardiol 95 (2005): 915-8. [PMID: 15781034]
107	Mokwe EO, Ositadinma O "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966000]
108	Sala M, Anguera I, Cervantes M "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966001]
109	Walker PW, Klein D, Kasza L "High dose methadone and ventricular arrhythmias: a report of three cases." Pain 103 (2003): 321-4. [PMID: 12791438]
110	Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
111	Goto M, Sato M, Kitzazawa H, et.al "Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation." Intern Med 53 (2014): 1629-31. [PMID: 25088875]
112	Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y "QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine." Cardiology 84 (1994): 9-13. [PMID: 7511988]
113	Jain A, Jenkins MG "Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine." Cathet Cardiovasc Diagn 18 (1989): 255-7. [PMID: 2605630]
114	Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T "Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve." Cathet Cardiovasc Diagn 19 (1990): 229-36. [PMID: 2334953]
115	Nakayama M, Saito A, Kitazawa H, et.al "Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases." Intern Med 51 (2012): 351-6. [PMID: 22333368]
116	Nakayama M, Tanaka N, Sakoda K, et.al "Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease." Circ J 79 (2015): 530-6. [PMID: 25746536]
117	Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML "Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine." J Am Coll Cardiol 15 (1990): 275-8. [PMID: 2299067]
118	Vrolix M, Piessens J, De Geest H "Torsades de pointes after intracoronary papaverine." Eur Heart J 12 (1991): 273-6. [PMID: 2044564]
119	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
120	Anson BD, Weaver JG, Ackerman MJ, et al. "Blockade of HERG channels by HIV protease inhibitors." Lancet 365 (2005): 682-686. [PMID: 15721475]
121	Biondi L "Health Canada endorsed important safety information on Invirase (saquinavir mesylate)." .
122	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
123	FDA. U.S. Food and Drug Administration "FDA drug safety communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms.".
124	Demolis JL, Charransol A, Funck-Brentano C, Jaillon P "Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers." Br J Clin Pharmacol 41 (1996): 499-503. [PMID: 8799513]
125	Dupont H, Timsit JF, Souweine B, Gachot B, Wolff M, Regnier B "Torsades de pointe probably related to sparfloxacin." Eur J Clin Microbiol Infect Dis 15 (1996): 350-1. [PMID: 8781892]
126	Jaillon P, Morganroth J, Brumpt I, Talbot G "Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group." J Antimicrob Chemother 37(suppl a) (1996): 161-7. [PMID: 8737135]
127	Lipsky BA, Dorr MB, Magner DJ, Talbot GH "Safety profile of sparfloxacin, a new fluoroquinolone antibiotic." Clin Ther 21 (1999): 148-59. [PMID: 10090432]
128	Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
129	Zix JA, GeerdesFenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
130	Product Information. Barhemsys (amisulpride). Acacia Pharma, Inc, Indianapolis, IN.
131	Product Information. Ayvakit (avapritinib). Blueprint Medicines Corporation, Cambridge, MA.
132	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
133	Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
134	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
135	Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
136	Product Information. Ferriprox (deferiprone). ApoPharma USA Inc, Rockville, MD.
137	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports."
138	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
139	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
140	Product Information. Exforge HCT (amlodipine/hydrochlorothiazide/valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
141	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
142	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
143	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
144	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
145	Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
146	Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
147	Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
148	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
149	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
150	Product Information. Signifor (pasireotide). Novartis Pharmaceuticals, East Hanover, NJ.
151	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
152	Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
153	Product Information. Uroxatral (alfuzosin). sanofi-aventis , Bridgewater, NJ.
154	Abbas R, Hug BA, Leister C, Sonnichsen D "A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects." Int J Cancer 131 (2012): Epub. [PMID: 22065400]
155	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
156	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
157	Product Information. Vandetanib (vandetanib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
158	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
159	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
160	Fletcher GF, Kazamias TM "Cardiotoxic effects of Mellaril: conduction disturbances and supraventricular arrhythmias." Am Heart J 78 (1969): 135-8. [PMID: 5794785]
161	Hartigan-Go K, Bateman DN, Nyberg G, Martensson E, Thomas SHL "Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans." Clin Pharmacol Ther 60 (1996): 543-53. [PMID: 8941027]
162	Liberatore MA, Robinson DS "Torsade de pointes: a mechanism for sudden death associated with neuroleptic drug therapy?" J Clin Psychopharmacol 4 (1984): 143-6. [PMID: 6145728]
163	Product Information. Mellaril (thioridazine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
164	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
165	Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.
166	Product Information. Eligard (leuprolide). Sanofi Winthrop Pharmaceuticals, New York, NY.
167	Product Information. Firmagon (degarelix). Ferring Pharmaceuticals Inc, Tarrytown, NY.
168	Product Information. Lupron (leuprolide). TAP Pharmaceuticals Inc, Deerfield, IL.
169	Product Information. Plenaxis (abarelix). Praecis Pharmaceuticals Inc, Waltham, MA.
170	Product Information. Trelstar (triptorelin) Pharmacia and Upjohn, Kalamazoo, MI.
171	Product Information. Vantas (histrelin). Endo Pharmaceuticals (formally Indevus Pharmaceuticals Inc), Lexington, MA.
172	Product Information. Zoladex (goserelin). Zeneca Pharmaceuticals, Wilmington, DE.
173	Canadian Pharmacists Association "e-CPS."
174	Abad S, Moachon L, Blanche P, Bavoux F, Sicard D, Salmon-Ceron D "Possible interaction between glicazide, fluconazole and sulfamethoxazole resulting in severe hypoglycaemia." Br J Clin Pharmacol 52 (2001): 456-7. [PMID: 11678792]
175	Ahmad S "Drug interaction induces hypoglycemia." J Fam Pract 40 (1995): 540-1. [PMID: 7775905]
176	Ahmad S "Gemfibrozil: interaction with glyburide." South Med J 84 (1991): 102. [PMID: 1898783]
177	Aleyassine H, Gardiner RJ "Dual action of antidepressant drugs (MAO inhibitors) on insulin release." Endocrinology 96 (1975): 702-10. [PMID: 1090438]
178	Aleyassine H, Lee SH "Inhibition of insulin release by substrates and inhibitors of monoamine oxidase." Am J Physiol 222 (1972): 565-9. [PMID: 5022664]
179	Almirall J, Montoliu J, Torras A, Revert L "Propoxyphene-induced hypoglycemia in a patient with chronic renal failure." Nephron 53 (1989): 273-5. [PMID: 2797348]
180	Arauz-Pacheco C, Ramirez LC, Rios JM, Raskin P "Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy." Am J Med 89 (1990): 811-3. [PMID: 2123605]
181	Asplund K, Wiholm BE, Lithner F "Glibenclamide-associated hypoglycaemia: a report on 57 cases." Diabetologia 24 (1983): 412-7. [PMID: 6411511]
182	Baciewicz AM, Swafford WB Jr "Hypoglycemia induced by the interaction of chlorpropamide and co-trimoxazole." Drug Intell Clin Pharm 18 (1984): 309-10. [PMID: 6609055]
183	Barbato M "Another problem with Kinidin." Med J Aust 141 (1984): 685. [PMID: 6436654]
184	Baron SH "Salicylates as hypoglycemic agents." Diabetes Care 5 (1982): 64-71. [PMID: 6754304]
185	Cacoub P, Deray G, Baumelou A, Grimaldi A, Soubrie C, Jacobs C "Disopyramide-induced hypoglycemia: case report and review of the literature." Fundam Clin Pharmacol 3 (1989): 527-35. [PMID: 2691378]
186	Cattaneo AG, Caviezel F, Pozza G "Pharmacological interaction between tolbutamide and acetylsalicylic acid: study on insulin secretion in man." Int J Clin Pharmacol Ther Toxicol 28 (1990): 229-34. [PMID: 2198232]
187	Christensen LK, Hansen JM, Kristensen M "Sulphaphenazole-induced hypoglycemic attacks in tolbutamide-treated diabetics." Lancet 2 (1963): 1298-301. [PMID: 14071924]
188	Cooper AJ, Ashcroft G "Potentiation of insulin hypoglycaemia by M.A.O.I. antidepressant drugs." Lancet 1 (1966): 407-9. [PMID: 4159787]
189	Croxson MS, Shaw DW, Henley PG, Gabriel HDLL "Disopyramide-induced hypoglycaemia and increased serum insulin." N Z Med J July (1987): 407-8. [PMID: 3330586]
190	Darcy PF, Griffin JP "Interactions with drugs used in the treatment of depressive illness." Adverse Drug React Toxicol Rev 14 (1995): 211-31. [PMID: 8845455]
191	Daubresse JC, Daigneux D, Bruwier M, Luyckx A, Lefebvre PJ "Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents." Br J Clin Pharmacol 7 (1979): 599-603. [PMID: 380614]
192	Daubresse JC, Luyckx AS, Lefebvre PJ "Potentiation of hypoglycemic effect of sulfonylureas by clofibrate." N Engl J Med 294 (1976): 613. [PMID: 1246250]
193	David DS, Steere AC Jr, Pi-Sunyer XF, Sakai S, Clark SB "Aspirin-induced hypoglycaemia in a patient on haemodialysis." Lancet 2 (1971): 1092-3. [PMID: 4106934]
194	Davis TM, Karbwang J, Looareesuwan S, et al "Comparative effects of quinine and quinidine on glucose metabolism in healthy volunteers." Br J Clin Pharmacol 30 (1990): 397-403. [PMID: 2223418]
195	de Salcedo I, Gorringe AL, Silva JL, Santos JA "Gemfibrozil in a group of diabetics." Proc R Soc Med 69 (1976): 64-70. [PMID: 1019155]
196	Deeg MA, Lipkin EW "Hypoglycemia associated with the use of fluoxetine." West J Med 164 (1996): 262-3. [PMID: 8775944]
197	Diwan PV, Sastry MS, Satyanarayana NV "Potentiation of hypoglycemic response of glibenclamide by piroxicam in rats and humans." Indian J Exp Biol 30 (1992): 317-9. [PMID: 1459600]
198	Feher MD, Amiel S "ACE inhibitors and hypoglycaemia." Lancet 346 (1995): 125-6. [PMID: 7603199]
199	Feldman JM, Chapman B "Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insulin secretion." Diabetologia 11 (1975): 487-94. [PMID: 1107123]
200	Ferrari C, Fressati S, Romussi M, et al. "Effects of short-term clofibrate administration on glucose tolerance and insulin secretion in patients with chemical diabetes or hypertriglyceridemia." Metabolism 26 (1977): 129-39. [PMID: 834147]
201	Ferriere M, Lachkar H, Richard JL, Bringer J, Orsetti A, Mirouze J "Captopril and insulin sensitivity." Ann Intern Med 102 (1985): 134-5. [PMID: 3881067]
202	Field JB, Ohta M, Boyle C, Remer A "Potentiation of acetohexamide hypoglycemia by phenylbutazone." N Engl J Med 277 (1967): 889-94. [PMID: 6061822]
203	Fogari R, Zoppi A, Corradi L, Pierangelo L, Mugellini A, Lusardi P "Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertension." Br J Clin Pharmacol 46 (1998): 467-71. [PMID: 9833600]
204	Giugliano D, Ceriello A, Saccomanno F, et al "Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus." J Clin Endocrinol Metab 61 (1985): 160-6. [PMID: 3923028]
205	Goldberg IJ, Brown LK, Rayfield EJ "Disopyramide (norpace)-induced hypoglycemia." Am J Med 69 (1980): 463-6. [PMID: 6998294]
206	Harris EL "Adverse reactions to oral antidiabetic agents." Br Med J 3 (1971): 29-30. [PMID: 5091891]
207	Harrison LC, King-Roach A, Martin FI, Melick RA "The effect of fenfluramine on insulin binding and on basal and insulin-stimulated oxidation of 1-C-glucose by human adipose tissue." Postgrad Med J 51 Suppl 1 (1975): 110-4. [PMID: 1219664]
208	Hartmann D, Korn A, Komjati M, Heinz G, Haefelfinger P, Defoin R, Waldhausl WK "Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide." Br J Clin Pharmacol 30 (1990): 245-52. [PMID: 2119677]
209	Hayashi S, Horie M, Tsuura Y, Ishida H, Okada Y, Seino Y, Sasayama S "Disopyramide blocks pancreatic ATP-sensitive K+ channels and enhances insulin release." Am J Physiol 265 (1993): c337-42. [PMID: 8368263]
210	Hekimsoy Z, Biberoglu S, Comlekci A, Tarhan O, Mermut C, Biberoglu K "Trimethoprim/sulfamethoxazole-induced hypoglycemia in a malnourished patient with severe infection." Eur J Endocrinol 136 (1997): 3046. [PMID: 9100556]
211	Hellman B "Potentiating effects of drugs on the binding of glibenclamide to pancreatic beta cells." Metabolism 23 (1974): 839-46. [PMID: 4212254]
212	Herings RMC, Deboer A, Stricker BHC, Leufkens HGM, Porsius A "Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme." Lancet 345 (1995): 1195-8. [PMID: 7739305]
213	Hundal RS, Petersen KF, Mayerson AB, et al "Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes." J Clin Invest 109 (2002): 1321-6. [PMID: 12021247]
214	Iida H, Morita T, Suzuki E, Iwasawa K, Toyooka T, Nakajima T "Hypoglycemia induced by interaction between clarithromycin and disopyramide." Jpn Heart J 40 (1999): 91-6. [PMID: 10370402]
215	Johnson J, Dobmeier M "Symptomatic hypoglycemia secondary to a glipizide-trimethoprim/sulfamethoxazole drug interaction." DICP 24 (1990): 250-1. [PMID: 2316232]
216	Johnson JA, Kappel JE, Sharif MN "Hypoglycemia secondary to trimethoprim/sulfamethoxazole administration in a renal transplant patient." Ann Pharmacother 27 (1993): 304-6. [PMID: 8453166]
217	Konttinen A, Kuisma I, Ralli R, Pohjola S, Ojala K "The effect of gemfibrozil on serum lipids in diabetic patients." Ann Clin Res 11 (1979): 240-5. [PMID: 398183]
218	Kradjan WA, Witt DM, Opheim KE, Wood FC "Lack of interaction between glipizide and co-trimoxazole." J Clin Pharmacol 34 (1994): 997-1002. [PMID: 7836551]
219	Kubacka RT, Antla EJ, Juhl RP, Welshman IR "Effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects." Ann Pharmacother 30 (1996): 20-6. [PMID: 8773160]
220	Lozada A, Dujovne CA "Drug interactions with fibric acids." Pharmacol Ther 63 (1994): 163-76. [PMID: 7809177]
221	Lumholtz B, Siersbaek-Nielsen K, Skovsted L, Kampmann J, Hansen JM "Sulfamethizole-induced inhibition of diphenylhydantoin, tolbutamide, and warfarin metabolism." Clin Pharmacol Ther 17 (1975): 731-4. [PMID: 1139863]
222	Morris AD, Newton RW, Boyle DI, et al. "ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes." Diabetes Care 20 (1997): 1363-7. [PMID: 9283780]
223	Morrison PJ, Rogers HJ, Spector RG, Bradbrook ID, John VA "Effect of pirprofen on glibenclamide kinetics and response." Br J Clin Pharmacol 14 (1982): 123-6. [PMID: 6809024]
224	Murakami K, Nambu S, Koh H, Kobayashi M, Shigeta Y "Clofibrate enhances the affinity of insulin receptors in non-insulin dependent diabetes mellitus." Br J Clin Pharmacol 17 (1984): 89-91. [PMID: 6362704]
225	Nakabayashi H, Ito T, Igawa T, Hiraiwa Y, Imamura T, Seta T, Kawato M, Usukura N, Takeda R "Disopyramide induces insulin secretion and plasma glucose diminution: studies using the in situ canine pancreas." Metabolism 38 (1989): 179-83. [PMID: 2643753]
226	Nappi JM, Dhanani S, Lovejoy JR, VanderArk C "Severe hypoglycemia associated with disopyramide." West J Med 138 (1983): 95-7. [PMID: 6404062]
227	Niemi M, Backman JT, Neuvonen M, Laitila J, Neuvonen PJ, Kivisto KT "Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride." Clin Pharmacol Ther 69 (2001): 194-200. [PMID: 11309547]
228	Nikkila EA, Ylikahri R, Huttunen JK "Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia." Proc R Soc Med 69 (1976): 58-63. [PMID: 190608]
229	Paolisso G, Balbi V, Gambardella A, Varricchio G, Tortoriello R, Saccomanno F, Amato L, Varricchio M "Lisinopril administration improves insulin action in aged patients with hypertension." J Hum Hypertens 9 (1995): 541-6. [PMID: 7562882]
230	Pestell RG, Crock PA, Ward GM, Alford FP, Best JD "Fenfluramine increases insulin action in patients with NIDDM." Diabetes Care 12 (1989): 252-8. [PMID: 2495916]
231	Petitpierre B, Perrin L, Rudhardt M, et al "Behaviour of chlorpropamide in renal insufficiency and under the effect of associated drug therapy." Int J Clin Pharmacol 6 (1972): 120-4. [PMID: 4638970]
232	Phillips AF, Matty PJ, Porte PJ, Raye JR "Inhibition of glucose-induced insulin secretion by indomethacin and sodium salicylate in the fetal lamb." Am J Obstet Gynecol 148 (1984): 481-7. [PMID: 6364813]
233	Phillips RE, Looareesuwan S, White NJ, et al "Hypoglycaemia and antimalarial drugs: quinidine and release of insulin." Br Med J 292 (1986): 1319-21. [PMID: 3085830]
234	Pollak PT, Mukherjee SD, Fraser AD "Sertraline-induced hypoglycemia." Ann Pharmacother 35 (2001): 1371-4. [PMID: 11724085]
235	Pond SM, Birkett DJ, Wade DN "Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole." Clin Pharmacol Ther 22 (1977): 573-9. [PMID: 913025]
236	Prince RL, Larkins RG, Alford FP "The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects." Metabolism 30 (1981): 293-8. [PMID: 7010074]
237	Product Information. Amaryl (glimepiride). Hoechst Marion-Roussel Inc, Kansas City, MO.
238	Product Information. Apidra (insulin glulisine). Aventis Pharmaceuticals, Bridgewater, NJ.
239	Product Information. Diabeta (glyburide). Hoechst Marion-Roussel Inc, Kansas City, MO.
240	Product Information. Diabinese (chlorpropamide). Pfizer US Pharmaceuticals, New York, NY.
241	Product Information. Dymelor (acetohexamide) Lilly, Eli and Company, Indianapolis, IN.
242	Product Information. Glucotrol (glipizide). Pfizer US Pharmaceuticals, New York, NY.
243	Product Information. Increlex (mecasermin). Tercica Inc, Brisbane, CA.
244	Product Information. Micronase (glyburide). Pharmacia and Upjohn, Kalamazoo, MI.
245	Product Information. Orinase (tolbutamide) Pharmacia and Upjohn, Kalamazoo, MI.
246	Product Information. Prandin (repaglinide). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
247	Product Information. Starlix (nateglinide) Novartis Pharmaceuticals, East Hanover, NJ.
248	Product Information. Tolinase (tolazamide) Pharmacia and Upjohn, Kalamazoo, MI.
249	Quevedo SF, Krauss DS, Chazan JA, et al "Fasting hypoglycemia secondary to disopyramide therapy." JAMA 245 (1981): 2424. [PMID: 6785461]
250	Ravic M, Johnston A, Turner P "Clinical pharmacological studies of some possible interactions of lornoxicam with other drugs." Postgrad Med J 66 (1990): s30-4. [PMID: 2126624]
251	Richardson T, Foster J, Mawer GE "Enhancement by sodium salicylate of the blood glucose lowering effect of chlorpropamide-drug interaction or summation of similar effects." Br J Clin Pharmacol 22 (1986): 43-8. [PMID: 3527244]
252	Rubin M, Zakheim B, Pitchumoni C "Disopyramide-induced profound hypoglycemia." N Y State J Med July,Aug,S (1983): 1057-8. [PMID: 6579404]
253	Salmela PI, Sotaniemi EA, Viikari J, et al "Fenfluramine therapy in non-insulin-dependent diabetic patients effects on body weight, glucose homeostasis, serum lipoproteins, and antipyrine metabolism." Diabetes Care 4 (1981): 535-40. [PMID: 6751729]
254	Sawka AM, Burgart V, Zimmerman D "Loss of awareness of hypoglycemia temporally associated with selective serotonin reuptake inhibitors." Diabetes Care 24 (2001): 1845-6. [PMID: 11574457]
255	Semel JD, Wortham E, Karl DM "Fasting hypoglycemia associated with disopyramide." Am Heart J 106 (1983): 1160-1. [PMID: 6356848]
256	Shah SJ, Bhandarkar SD, Satoskar RS "Drug interaction between chlorpropamide and non-steroidal anti-flammatory drugs, ibuprofen and phenylbutazone." Int J Clin Pharmacol Ther Toxicol 22 (1984): 470-2. [PMID: 6500764]
257	Sievenpiper JL, Arnason JT, Leiter LA, Vuksan V "Variable effects of American ginseng: a batch of American ginseng (Panax quinquefolius L.) with a depressed ginsenoside profile does not affect postprandial glycemia." Eur J Clin Nutr 57 (2003): 243-8. [PMID: 12571655]
258	Sjoberg S, Wiholm BE, Gunnarsson R, Emilsson H, Thunberg E, Christenson I, Ostman J "Lack of pharmacokinetic interaction between glibenclamide and trimethoprim-sulphamethoxazole." Diabet Med 4 (1987): 245-7. [PMID: 2956028]
259	Slade IH, and Iosefa RN "Fatal hypoglycemic coma from the use of tolbutamide in elderly patients: report of two cases." J Am Geriatr Soc 15 (1967): 948-50. [PMID: 6046558]
260	Sone H, Takahashi A, Yamada N "Ibuprofen-related hypoglycemia in a patient receiving sulfonylurea." Ann Intern Med 134 (2001): 344. [PMID: 11182854]
261	Storlien LH, Thorburn AW, Smythe GA, Jenkins AB, Chisholm DJ, Kraegen EW "Effect of d-fenfluramine on basal glucose turnover and fat-feeding-induced insulin resistance in rats." Diabetes 38 (1989): 499-503. [PMID: 2647557]
262	Strathman I, Schubert EN, Cohen A, Nitzberg DM "Hypoglycemia in patients receiving disopyramide phosphate." Drug Intell Clin Pharm 17 (1983): 635-8. [PMID: 6413187]
263	Tannenbaum H, Anderson LG, Soeldner JS "Phenylbutazone-tolbutamide drug interaction." N Engl J Med 290 (1974): 344. [PMID: 4809290]
264	Tran PO, Gleason CE, Robertson RP "Inhibition of interleukin-1beta-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function." Diabetes 51 (2002): 1772-8. [PMID: 12031964]
265	Tremaine LM, Wilner KD, Preskorn SH "A study of the potential effect of sertraline on the pharmacokinetics and protein binding of tolbutamide." Clin Pharmacokinet 32(Suppl 1) (1997): 31-36. [PMID: 9068933]
266	Turtle JR, Burgess JA "Hypoglycemic action of fenfluramine in diabetes mellitus." Diabetes 22 (1973): 858-67. [PMID: 4749404]
267	Verdy M, Charbonneau L, Verdy I, Belanger R, Bolte E, Chiasson JL "Fenfluramine in the treatment of non-insulin-dependent diabetics: hypoglycemic versus anorectic effect." Int J Obes 7 (1983): 289-97. [PMID: 6629637]
268	Vuksan V, Sievenpiper JL, Koo VY, et al "American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus." Arch Intern Med 160 (2000): 1009-13. [PMID: 10761967]
269	Vuksan V, Stavro MP, Sievenpiper JL, et al "Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes." Diabetes Care 23 (2000): 1221-6. [PMID: 10977009]
270	Whitcroft IA, Thomas JM, Rawsthorne A, et al "Effects of alpha and beta adrenoceptor blocking drugs and ACE inhibitors on long term glucose and lipid control in hypertensive non-insulin dependent diabetics." Horm Metab Res Suppl 22 (1990): 42-6. [PMID: 1975246]
271	Wiederholt IC, Genco M, Foley JM "Recurrent episodes of hypoglycemia induced by propoxyphene." Neurology 17 (1967): 703-6. [PMID: 6067489]
272	Wing LM, Miners JO "Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition." Br J Clin Pharmacol 20 (1985): 482-5. [PMID: 3878154]
273	World Health Organization "WHO Public Assessment Reports (WHOPARs).".
274	Wu B, Sato T, Kiyosue T, Arita M "Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs." Cardiovasc Res 26 (1992): 1095-101. [PMID: 1291087]
275	Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7. [PMID: 7838793]
276	Teodorovich N, Margolin E, Kogan Y, Paz O, Swissa M. Torsades de pointes after adenosine administration. J Electrocardiol. 2016;49(2):171-173. [PMID: 26850499]
277	Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301. [PMID: 8131497]
278	Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10. [PMID: 15208219]
279	Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422. [PMID: 1392935]
280	Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6. [PMID: 1539535]
281	Product Information. Sporanox (itraconazole). Janssen Pharmaceutica, Titusville, NJ.
282	Product Information. Apokyn (apomorphine). Mylan Pharmaceuticals Inc, Morgantown, WV.
283	Goodnick PJ, Jerry J, Parra F "Psychotropic drugs and the ECG: focus on the QTc interval." Expert Opin Pharmacother 3 (2002): 479-98. [PMID: 11996627]
284	Kane JM, Carson WH, Saha AR, et al. "Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder." J Clin Psychiatry 63 (2002): 763-71. [PMID: 12363115]
285	Keck PE Jr, Marcus R, Tourkodimitris S, et al. "A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania." Am J Psychiatry 160 (2003): 1651-8. [PMID: 12944341]
286	Nelson S, Leung JG "Torsades de Pointes After Administration of Low-Dose Aripiprazole (February)." Ann Pharmacother (2013):. [PMID: 23362038]
287	Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG "Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study." J Clin Psychiatry 64 (2003): 1048-56. [PMID: 14628980]
288	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
289	Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
290	Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
291	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
292	Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
293	Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
294	Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
295	Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
296	Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
297	Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
298	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
299	Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
300	Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
301	Product Information. Lamprene (clofazimine). Novartis Pharmaceuticals, East Hanover, NJ.
302	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
303	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
304	Product Information. Exelon (rivastigmine) Novartis Pharmaceuticals, East Hanover, NJ.
305	Product Information. Razadyne (galantamine). Johnson and Johnson Medical Inc, Arlington, TX.
306	Product Information. Pepcid (famotidine). Merck & Co, Inc, West Point, PA.
307	Bengtsson B, Fagerstrom PO "Extrapulmonary effects of terbutaline during prolonged administration." Clin Pharmacol Ther 31 (1982): 726-32. [PMID: 7042176]
308	Braden GL, vonOeyen PT, Germain MJ, Watson DJ, Haag BL "Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences." Kidney Int 51 (1997): 1867-75. [PMID: 9186877]
309	Clifton GD, Hunt BA, Patel RC, Burki NK "Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses." Am Rev Respir Dis 141 (1990): 575-9. [PMID: 2178522]
310	Dickens GR, Mccoy RA, West R, Stapczynski JS, Clifton GD "Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease." Pharmacotherapy 14 (1994): 729-33. [PMID: 7885977]
311	Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C "Cardiovascular Safety of Salmeterol in COPD." Chest 123 (2003): 1817-24. [PMID: 12796155]
312	Gelmont DM, Balmes JR, Yee A "Hypokalemia induced by inhaled bronchodilators." Chest 94 (1988): 763-6. [PMID: 3168573]
313	Gross TL, Sokol RJ "Severe hypokalemia and acidosis: a potential complication of beta- adrenergic treatment." Am J Obstet Gynecol 138 (1980): 1225-6. [PMID: 7446635]
314	Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9. [PMID: 708661]
315	Hurlbert BJ, Edelman JD, David K "Serum potassium levels during and after terbutaline." Anesth Analg 60 (1981): 723-5. [PMID: 7197475]
316	Hypokalaemia due to salbutamol overdosage. Br Med J (Clin Res Ed) 283 (1981): 500-1. [PMID: 6114774]
317	Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20. [PMID: 3956296]
318	Lowe MD, Rowland E, Brown MJ, Grace AA "Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium." Heart 86 (2001): 45-51. [PMID: 11410561]
319	Milic M, Bao X, Rizos D, Liu F, Ziegler MG "Literature review and pilot studies of the effect of qt correction formulas on reported beta(2)-agonist-induced QTc prolongation." Clin Ther 28 (2006): 582-90. [PMID: 16750469]
320	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
321	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
322	Product Information. Brovana (arformoterol). Sepracor Inc, Marlborough, MA.
323	Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
324	Product Information. Maxair (pirbuterol). 3M Pharmaceuticals, St. Paul, MN.
325	Product Information. Proventil (albuterol). Schering Laboratories, Kenilworth, NJ.
326	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
327	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
328	Product Information. Xopenex (levalbuterol). Sepracor, Marlborough, MA.
329	Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7. [PMID: 9583400]
330	Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA "Metabolic and cardiovascular effects of carbuterol and metaproterenol." J Allergy Clin Immunol 60 (1977): 174-9. [PMID: 19514]
331	Sun ZH, Swan H, Vitasalo M, Toivonen L "Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome." J Am Coll Cardiol 31 (1998): 1400-5. [PMID: 9581741]
332	Tveskov C, Djurhuus MS, Klitgaard NAH, Egstrup K "Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta(2)-adrenergic stimulation with terbutaline in healthy subjects." Chest 106 (1994): 1654-9. [PMID: 7988180]
333	Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71. [PMID: 3545273]
334	Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R "A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol." N Z Med J 103 (1990): 259-61. [PMID: 1972557]
335	Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9. [PMID: 1978872]
336	Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9. [PMID: 921062]
337	Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
338	Ben Salem C, Fathallah N, Hmouda H, Bouraoui K "Drug-induced hypoglycaemia: an update." Drug Saf 34 (2011): 21-45. [PMID: 20942513]
339	Product Information. Afrezza (insulin inhalation, rapid acting). MannKind Corporation, Valencia, CA.
340	Product Information. Humalog (insulin lispro). Lilly, Eli and Company, Indianapolis, IN.
341	Product Information. Humulin 70/30 (insulin isophane-insulin regular). Lilly, Eli and Company, Indianapolis, IN.
342	Product Information. Ryzodeg 70/30 FlexTouch (insulin aspart-insulin degludec). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
343	Product Information. Tresiba FlexTouch (insulin degludec). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
344	Vuorinen-Markkola H, Yki-Jarvinen H "Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus." Metabolism 44 (1995): 85-9. [PMID: 7854171]
345	Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
346	Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
347	Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
348	Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
349	Chin RL "Laxative-induced hypokalemia." Ann Emerg Med 32 (1998): 517-8. [PMID: 9774942]
350	Muller-Lissner SA "Adverse effects of laxatives: fact and fiction." Pharmacology 47 (1993): 138-45. [PMID: 8234421]
351	Schaefer DC, Cheskin LJ "Constipation in the elderly." Am Fam Physician 58 (1998): 907-14. [PMID: 9767726]
352	Product Information. Tykerb (lapatinib). Novartis Pharmaceuticals, East Hanover, NJ.
353	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs. Prolongation of QT interval is probably a class effect of fluoroquinolones." Br Med J 322 (2001): 46-7. [PMID: 11141163]
354	Kahn JB "Latest industry information on the safety profile of levofloxacin in the US." Chemotherapy 47 Suppl 3 (2001): 32-7. [PMID: 11549787]
355	Makaryus AN, Byrns K, Makaryus MN, Natarajan U, Singer C, Goldner B "Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?" South Med J 99 (2006): 52-6. [PMID: 16466123]
356	Nykamp DL, Blackmon CL, Schmidt PE, Roberson AG "QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine." Ann Pharmacother 39 (2005): 543-6. [PMID: 15687478]
357	Product Information. Floxin (ofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
358	Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
359	Samaha FF "QTC interval prolongation and polymorphic ventricular tachycardia in association with levofloxacin." Am J Med 107 (1999): 528-9. [PMID: 10569314]
360	Eggleston W, Clark KH, Marraffa JM "Loperamide abuse associated with cardiac dysrhythmia and death." Ann Emerg Med 69 (2017): 83-6. [PMID: 27140747]
361	US Food and Drug Administration "FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse.".
362	Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
363	Product Information. Remeron (mirtazapine). Organon, West Orange, NJ.
364	Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
365	Product Information. Zyprexa (olanzapine). Lilly, Eli and Company, Indianapolis, IN.
366	Product Information. Definity (perflutren). Lantheus Medical Imaging Inc, North Billerica, MA.
367	Product Information. Optison (perflutren). Mallinckrodt Medical Inc, St. Louis, MO.
368	Hanci V, Aydin M, Yurtlu BS, et.al "Anesthesia induction with sevoflurane and propofol: evaluation of P-wave dispersion, QT and corrected QT intervals." Kaohsiung J Med Sci 26 (2010): 470-7. [PMID: 20837343]
369	Kim DH, Kweon TD, Nam SB, Han DW, Cho WY, Lee JS "Effects of target concentration infusion of propofol and tracheal intubation on QTc interval." Anaesthesia 63 (2008): 1061-4. [PMID: 18717665]
370	Kleinsasser A, Kuenszberg E, Loeckinger A, et.al "Sevoflurane, but not propofol, significantly prolongs the Q-T interval." Anesth Analg 90 (2000): 25-7. [PMID: 10624970]
371	Kleinsasser A, Loeckinger A, Lindner KH, Keller C, Boehler M, Puehringer F "Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol." Anaesthesia 56 (2001): 248-50. [PMID: 11251432]
372	Paventi S, Santevecchi A, Ranieri R "Effects of sevoflurane versus propofol on QT interval." Minerva Anestesiol 67 (2001): 637-40. [PMID: 11731753]
373	Scalese MJ, Herring HR, Rathburn RC, Skrepnek GH, Ripley TL "Propofol-associated QTc prolongation." Ther Adv Drug Saf 7 (2016): 68-78. [PMID: 27298717]
374	Staikou C, Stamelos M, Stavroulakis E "Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity." Br J Anaesth 112 (2014): 217-30. [PMID: 24305646]
375	Toyoda T, Terao Y, Oji M, Okada M, Fukusaki M, Sumikawa K "The interaction of antiemetic dose of droperidol with propofol on QT interval during anesthetic induction." J Anesth 27 (2013): 885-9. [PMID: 23660990]
376	Whyte SD, Booker PD, Buckley DG "The Effects of Propofol and Sevoflurane on the QT Interval and Transmural Dispersion of Repolarization in Children." Anesth Analg 100 (2005): 71-77. [PMID: 15616054]
377	Wutzler A, De Asmundis C, Matsuda H, et.al "Effects of propofol on ventricular repolarization and incidence of malignant arrhythmias in adults." J Electrocardiol 51 (2018): 170-4. [PMID: 29174097]
378	Product Information. Seroquel (quetiapine). Zeneca Pharmaceuticals, Wilmington, DE.
379	Sala M, Vicentini A, Brambilla P, et al. "QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy." Ann Gen Psychiatry 4 (2005): 1. [PMID: 15845138]
380	Vieweg WV "New generation antipsychotic drugs and QTc interval prolongation." Prim Care Companion J Clin Psychiatry 5 (2003): 205-15. [PMID: 15213787]
381	Vieweg WV, Schneider RK, Wood MA "Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine." Acta Psychiatr Scand 112 (2005): 318-22. [PMID: 16156840]
382	European Medicines Agency "CHMP Assessment Report for Latixa. International nonproprietary name: ranolazine.".
383	Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.
384	Product Information. Ultane (sevoflurane). Abbott Pharmaceutical, Abbott Park, IL.
385	Product Information. Nexavar (sorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
386	Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
387	Product Information. Kaletra (lopinavir-ritonavir) Abbott Pharmaceutical, Abbott Park, IL.
388	Product Information. Alecensa (alectinib). Genentech, South San Francisco, CA.
389	Product Information. Saphris (asenapine). Schering-Plough Corporation, Kenilworth, NJ.
390	Product Information. Orladeyo (berotralstat). BioCryst Pharmaceuticals Inc, Durham, NC.
391	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
392	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
393	Product Information. Austedo (deutetrabenazine). Teva Pharmaceuticals USA, North Wales, PA.
394	Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
395	Gorski JC, Huang SM, Pinto A, et al. "The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo." Clin Pharmacol Ther 75 (2004): 89-100. [PMID: 14749695]
396	Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
397	Product Information. Halaven (eribulin). Eisai Inc, Teaneck, NJ.
398	Product Information. Inrebic (fedratinib). Celgene Corporation, Summit, NJ.
399	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
400	Product Information. Rukobia (fostemsavir). ViiV Healthcare, Research Triangle Park, NC.
401	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
402	Product Information. Daurismo (glasdegib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
403	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
404	Product Information. Besponsa (inotuzumab ozogamicin). Wyeth Laboratories, Philadelphia, PA.
405	Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
406	Product Information. Lucemyra (lofexidine). US WorldMeds LLC, Louisville , KY.
407	Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
408	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
409	Product Information. Nuplazid (pimavanserin). Accelis Pharma, East Windsor, NJ.
410	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
411	Gilead Sciences, Inc "About Remdesivir.".
412	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
413	Product Information. Evenity (romosozumab). Amgen USA, Thousand Oaks, CA.
414	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
415	Product Information. Ingrezza (valbenazine). Neurocrine Biosciences, Inc., San Diego, CA.
416	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
417	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
418	Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
419	Antonelli D, Atar S, Freedberg NA, Rosenfeld T "Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions." Isr Med Assoc J 7 (2005): 163-5. [PMID: 15792261]
420	Dattilo PB, Nordin C "Prolonged QT associated with an overdose of trazodone." J Clin Psychiatry 68 (2007): 1309-10. [PMID: 17854263]
421	Levenson JL "Prolonged QT interval after trazodone overdose." Am J Psychiatry 156 (1999): 969-70. [PMID: 10360146]
422	Mazur A, Strasberg B, Kusniec J, Sclarovsky S "QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination." Int J Cardiol 52 (1995): 27-9. [PMID: 8707432]
423	Product Information. Oleptro (traZODone). Labopharm Inc, Laval, AL.
424	Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F "QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone." Pacing Clin Electrophysiol 28 (2005): 472-3. [PMID: 15869686]
425	Product Information. Flagyl (metronidazole). Searle, Skokie, IL.
426	Product Information. Pylera (bismuth subcitrate potassium/metronidazo/TCN). Aptalis Pharma, Birmingham, AL.
427	Crouch MA, Limon L, Cassano AT "Clinical relevance and management of drug-related QT interval prolongation." Pharmacotherapy 23 (2003): 881-908. [PMID: 12885102]
428	Darpo B "Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes." Eur Heart J Suppl 3(Suppl K) (2001): K70-80.
429	Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T "QT prolongation and torsades de pointes after administration of trimethoprin-sulfamethoxazole." Am J Cardiol 59 (1987): 376-7. [PMID: 3492908]
430	Wiener I, Rubin D, Martinez E, et al "QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration." Mt Sinai J Med 48 (1981): 53-5. [PMID: 6970886]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence